| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |